By ANGELICA LAVITO AND FIONA RUTHERFORD | Bloomberg | Published: April 16, 2021
Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See more staff and wire stories here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.
Communities across the U.S. are suddenly revamping their vaccination campaigns to adjust to an indefinite halt in Johnson & Johnson's doses, which has required officials to reschedule tens of thousands of appointments as they seek to reassure people that covid-19 vaccines are safe.
Health professionals are split on whether the delay should continue. On the one hand, the blood-clotting syndrome that led to the pause in J&J vaccinations is serious and can be deadly. Conversely, with J&J doses out of circulation, that means fewer people are getting immunized even as fast-spreading covid variants are tightening their grip, and concern about the J&J shots risks expanding vaccine hesitancy.